(Q51374868)

4 April 2018

title

Phase I and pharmacokinetic clinical trial of oral administration of the acyclic retinoid NIK-333. (English)

1 reference

4 April 2018

main subject

phase I clinical trial

0 references

1 reference

Takuji Okusaka

1

1 reference

4 April 2018

Hideki Ueno

series ordinal

2

1 reference

4 April 2018

Masafumi Ikeda

series ordinal

3

1 reference

4 April 2018

Chigusa Morizane

series ordinal

4

1 reference

4 April 2018

publication date

19 April 2011

1 reference

4 April 2018

published in

Hepatology Research

1 reference

4 April 2018

volume

41

1 reference

4 April 2018

issue

6

1 reference

4 April 2018

page(s)

542-552

1 reference

4 April 2018

Inhibitory effects of acyclic retinoid (polyprenoic acid) and its hydroxy derivative on cell growth and on secretion of alpha-fetoprotein in human hepatoma-derived cell line (PLC/PRF/5).

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Chemoprevention of hepatocellular carcinoma by acyclic retinoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Isotretinoin-induced nail fragility and onycholysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

Lipid metabolism and retinoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1872-034X.2011.00800.X

10.1111/J.1872-034X.2011.00800.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018